Literature DB >> 11742966

Trials of corticosteroids to prevent postextubation airway complications.

M O Meade1, G H Guyatt, D J Cook, T Sinuff, R Butler.   

Abstract

We identified three randomized controlled trials (RCTs) that addressed whether preextubation steroid administration reduces postextubation complications in children. The pooled analysis of primary extubation in children demonstrated significantly less stridor (relative risk [RR], 0.57; 95% confidence interval [CI], 0.40 to 0.81) and a trend toward less reintubation (RR, 0.50; 95% CI, 0.02 to 13.87) with corticosteroids. One non-RCT in children who had failed extubation the first time found a significant reduction in duration of prolonged reintubation (> or = 6 days) and in failed reextubations. The four RCTs in adults reported very low reintubation rates, and no conclusions can be drawn. Only one RCT assessed postextubation stridor and found little difference. Overall, we found that corticosteroids decreased the risk of postextubation stridor in children by about 40%. However, the effect of corticosteroids in children and adults to reduce postextubation complications such as reintubation is uncertain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742966     DOI: 10.1378/chest.120.6_suppl.464s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Does dexamethasone reduce the risk of extubation failure in ventilated children?

Authors:  M A Lukkassen; D G Markhorst
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

2.  Post-intubation laryngeal injuries and extubation failure: a fiberoptic endoscopic study.

Authors:  Jean-Marc Tadié; Eva Behm; Lucien Lecuyer; Rania Benhmamed; Stéphane Hans; Daniel Brasnu; Jean-Luc Diehl; Jean-Yves Fagon; Emmanuel Guérot
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

3.  Randomized comparative efficacy of dexamethasone to prevent postextubation upper airway complications in children and adults in ICU.

Authors:  Dinesh Malhotra; Showkat Gurcoo; Shagufta Qazi; Satyadev Gupta
Journal:  Indian J Anaesth       Date:  2009-08

Review 4.  Corticosteroids to prevent extubation failure: a systematic review and meta-analysis.

Authors:  John McCaffrey; Clare Farrell; Paul Whiting; Arina Dan; Sean M Bagshaw; Anthony P Delaney
Journal:  Intensive Care Med       Date:  2009-04-08       Impact factor: 17.440

5.  Does prophylactic use of dexamethasone have a role in reducing post extubation stridor and reintubation in children?

Authors:  Ali Faisal Saleem; Surrayo Bano; Anwarul Haque
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

6.  Effect of nebulized budesonide in preventing postextubation complications in critically patients: A prospective, randomized, double-blind, placebo-controlled study.

Authors:  Saeed Abbasi; Siamak Moradi; Reihanak Talakoub; Parviz Kashefi; Ali Mehrabi Koushki
Journal:  Adv Biomed Res       Date:  2014-08-26

7.  Comparison of the efficacy of nebulized budesonide and intravenous dexamethasone administration before extubation in prevention of post-extubation complications among patients admitted in intensive care unit.

Authors:  Parviz Kashefi; Ali Abbasi; Mahnaz Abbasi; Leila Davoodi; Saeed Abbasi
Journal:  Adv Biomed Res       Date:  2015-01-06

8.  Facing the airway challenges in maxillofacial trauma: A retrospective review of 288 cases at a level i trauma center.

Authors:  Babita Gupta; Arunima Prasad; Sarita Ramchandani; Maneesh Singhal; Purva Mathur
Journal:  Anesth Essays Res       Date:  2015 Jan-Apr

Review 9.  Prophylactic administration of parenteral steroids for preventing airway complications after extubation in adults: meta-analysis of randomised placebo controlled trials.

Authors:  Tao Fan; Gang Wang; Bing Mao; Zeyu Xiong; Yu Zhang; Xuemei Liu; Lei Wang; Sai Yang
Journal:  BMJ       Date:  2008-10-20

10.  Corticosteroids to prevent postextubation upper airway obstruction: the evidence mounts.

Authors:  Scott K Epstein
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.